8 April
2024
Assura plc
Scrip Dividend
Declaration
Assura plc ("Assura" or "the
Company"), the UK's leading primary care property investor and
developer, today announces that, pursuant to its Scrip Dividend
Scheme and in response to the scrip dividend alternative for the
quarterly interim dividend payable on 10 April 2024 (the "Scrip
Dividend Alternative"), elections were received in respect of 8.3
per cent. of the Company's ordinary shares in issue as at the
record date of 8 March 2024.
Electing shareholders will receive
ordinary shares in the Company ("Shares") in lieu of cash in
respect of this dividend and, accordingly 4,663,894 Shares (the
"New Shares") will be issued by the Company to such
shareholders.
Application has therefore been made
for the admission of the New Shares to the Official List of the
Financial Conduct Authority and to trading on the London Stock
Exchange's market for listed securities ("Admission"). The New
Shares will rank pari passu with the Company's existing ordinary
shares and Admission is expected to occur at 8.00am on 10 April
2024.
Following the allotment of the New
Shares, it is expected that the total number of shares in issue
will be 2,989,454,390 (none of which will be held in treasury) and
that, accordingly, the total number of voting rights of the Company
will be 2,989,454,390.
Copies of the documents relating to
the Scrip Dividend Alternative are available for inspection through
the National Storage Mechanism (https://data.fca.org.uk/#/nsm/nationalstoragemechanism).
This interim dividend is 100%
Property Income Distribution ("PID"). Forms
to register for gross PIDs (on future interim dividends) are
available on the Company's website. Please click here for
PID Forms.
- ENDS
-
For more information, please
contact:
Assura plc
David Purcell, Investor Relations
Director
|
Tel: 0161 515 2043
Email: Investor@assura.co.uk
|
FGS
Global Gordon Simpson
|
Tel: 0207 251 3801
Email: Assura@fgsglobal.com
|
Notes to Editors
Assura plc is a national healthcare
premises specialist and UK REIT based in Altrincham, UK - caring
for more than 600 primary healthcare buildings, from which over six
million patients are served.
A constituent of the FTSE 250 and
the EPRA* indices, as at 30 September 2023, Assura's portfolio was
valued at £2.7 billion.
At Assura, we BUILD for health.
Assura builds better spaces for people and places, invests in
skills and inspires new ways of working, and unlocks the power of
design and innovation to deliver lasting impact for communities -
aiming for six million people to have benefitted from improvements
to and through its healthcare buildings by 2026.
Assura is leading for a sustainable
future, targeting net zero carbon across its portfolio by
2040.
Further information is available
at www.assuraplc.com
Assura plc LEI
code: 21380026T19N2Y52XF72
*EPRA is a registered trademark of
the European Public Real Estate Association.